Aderson O M C Damiao
Overview
Explore the profile of Aderson O M C Damiao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
160
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Quaresma A, Damiao A, Coy C, Magro D, Hino A, Valverde D, et al.
Lancet Reg Health Am
. 2023 Feb;
13:100298.
PMID: 36777324
Background: Population-based data on epidemiology of Inflammatory Bowel Diseases (IBD) in Brazil are scarce. This study aims to define temporal trends of incidence and prevalence rates of Crohn's disease (CD)...
2.
Kotze P, Heuthorst L, Lightner A, Damiao A, Bemelman W
Lancet Gastroenterol Hepatol
. 2022 Apr;
7(7):679-688.
PMID: 35364005
Despite substantial advances in medical therapy since 2005 that have led to the approval and increased use of novel biological agents and small molecules, colectomy is still a therapeutic option...
3.
Oba J, Sobrado C, Damiao A, Azevedo M, Carlos A, Queiroz N, et al.
Arq Gastroenterol
. 2021 Dec;
58(4):541-547.
PMID: 34909863
Background: Inflammatory bowel diseases (IBD), comprising Crohn's disease and ulcerative colitis, are chronic inflammatory diseases of the gastrointestinal tract that often have their onset among adolescents and young adults (AYA)....
4.
Sandborn W, Lawendy N, Danese S, Su C, Loftus Jr E, Hart A, et al.
Aliment Pharmacol Ther
. 2021 Dec;
55(4):464-478.
PMID: 34854095
Background: Tofacitinib is an oral, small molecule Janus kinase inhibitor for the treatment of ulcerative colitis. We present final data from OCTAVE Open, an open-label, long-term extension study. Aims: The...
5.
Kotze P, Teixeira F, Damiao A
Aliment Pharmacol Ther
. 2020 May;
51(11):1208-1209.
PMID: 32424919
No abstract available.
6.
Andrade A, Barros L, Azevedo M, Carlos A, Damiao A, Sipahi A, et al.
Clin Transl Gastroenterol
. 2018 Apr;
9(4):142.
PMID: 29618721
Objectives: Patients with inflammatory bowel disease have a higher risk of thrombosis, which is associated with a higher morbidity and mortality. Most data about VTE are related to hospitalized patients...
7.
Kotze P, Yamamoto T, Damiao A
Curr Drug Targets
. 2015 Nov;
19(7):729-739.
PMID: 26521776
Background: Recurrence is a common event after surgical resections secondary to Crohn's disease (CD). Endoscopic signs of inflammation, defined as postoperative endoscopic recurrence (PER) occur in up to 90% of...
8.
Alencar M, Ortiz-Agostinho C, Nishitokukado L, Damiao A, Abrantes-Lemos C, Leite A, et al.
Clinics (Sao Paulo)
. 2012 Sep;
67(9):1013-8.
PMID: 23018296
Objective: Celiac disease is a permanent enteropathy caused by the ingestion of gluten, which leads to an immunemediated inflammation of the small intestine mucosa. The prevalence of celiac disease varies...
9.
Pereira M, Ortiz-Agostinho C, Nishitokukado I, Sato M, Damiao A, Alencar M, et al.
World J Gastroenterol
. 2006 Oct;
12(40):6546-50.
PMID: 17072989
Aim: To determine the prevalence of celiac disease in a group of volunteer blood donors at a blood bank in the city of Curitiba, Brazil through detection of the serum...
10.
Bernardes-Silva C, Damiao A, Sipahi A, Laurindo F, Iriya K, Lopasso F, et al.
Dig Dis Sci
. 2004 Dec;
49(10):1569-74.
PMID: 15573906
The aim of this study was to evaluate the effect of ursodeoxycholic acid (UDCA) on intestinal permeability (IP) and reactive oxygen species (ROS) generation in indomethacin-induced enteropathy, a well-known experimental...